Aptevo Therapeutics Statistics

Total Valuation

APVO has a market cap or net worth of $11.41 million. The enterprise value is $13.70 million.

Market Cap	11.41M
Enterprise Value	13.70M

Important Dates

The next estimated earnings date is Thursday, August 7, 2025, before market open.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

APVO has 3.71 million shares outstanding.

Current Share Class	3.71M
Shares Outstanding	3.71M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+78.66%
Owned by Insiders (%)	0.00%
Owned by Institutions (%)	9.08%
Float	3.42M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.67

Current Ratio	0.67
Quick Ratio	0.40
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -1,023.93% and return on invested capital (ROIC) is -201.28%.

Return on Equity (ROE)	-1,023.93%
Return on Assets (ROA)	-115.99%
Return on Invested Capital (ROIC)	-201.28%
Return on Capital Employed (ROCE)	-817.19%
Revenue Per Employee	n/a
Profits Per Employee	-$640,649
Employee Count	37
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -99.20% in the last 52 weeks. The beta is 5.73, so APVO's price volatility has been higher than the market average.

Beta (5Y)	5.73
52-Week Price Change	-99.20%
50-Day Moving Average	7.20
200-Day Moving Average	88.47
Relative Strength Index (RSI)	33.62
Average Volume (20 Days)	6,643,732

Short Selling Information

The latest short interest is 11,418, so 0.31% of the outstanding shares have been sold short.

Short Interest	11,418
Short Previous Month	9,397
Short % of Shares Out	0.31%
Short % of Float	0.33%
Short Ratio (days to cover)	0.03

Income Statement

Revenue	n/a
Gross Profit	171,000
Operating Income	-24.10M
Pretax Income	-24.95M
Net Income	-23.70M
EBITDA	-23.79M
EBIT	-24.10M
Earnings Per Share (EPS)	-$745.27

Full Income Statement

Balance Sheet

The company has $2.14 million in cash and $4.42 million in debt, giving a net cash position of -$2.28 million or -$0.62 per share.

Cash & Cash Equivalents	2.14M
Total Debt	4.42M
Net Cash	-2.28M
Net Cash Per Share	-$0.62
Equity (Book Value)	-1.47M
Book Value Per Share	-20.20
Working Capital	-1.79M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-23.71M
Capital Expenditures	n/a
Free Cash Flow	-23.71M
FCF Per Share	-$6.40

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

APVO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-207.67%
FCF Yield	-207.71%

Analyst Forecast

The average price target for APVO is $5,920.00, which is 192,107.79% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5,920.00
Price Target Difference	192,107.79%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 27, 2025. It was a reverse split with a ratio of 0.05:1.

Last Split Date	May 27, 2025
Split Type	Reverse
Split Ratio	0.05:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a